This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours, Cancer Immunology Immunotherapy, October 2012, Springer Science + Business Media,
DOI: 10.1007/s00262-012-1357-7.
You can read the full text:
The following have contributed to this page
